Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia

脑脊液中 proNGF 水平作为额颞叶痴呆患者的潜在诊断生物标志物

阅读:7
作者:Francesca Malerba, Rita Florio, Ivan Arisi, Chiara Zecca, Maria Teresa Dell'Abate, Giancarlo Logroscino, Antonino Cattaneo

Discussion

These results suggest that proNGF could be included in a panel of biomarkers to improve the FTD diagnosis.

Methods

By the means of a new immunoassay, we have measured and analyzed the proNGF levels in 43 cerebrospinal fluids (CSF) from FTD patients, and compared the

Results

A statistically significant difference between proNGF levels in FTD compared to AD, SMC and controls subjects was found. The statistical models reveal that proNGF determination increases the accuracy of FTD diagnosis, if added to the clinically validated CSF biomarkers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。